Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2012-07-13

Clinical Trial Update: Oral Chemotherapy Versus Supportive Therapy In The Treatment Of Unresectable Hepatocellular Carcinoma [Phase 2, Phase 3]

View source ↗

Summary

An ongoing Phase 2/3 clinical trial compares oral chemotherapy to supportive therapy for unresectable hepatocellular carcinoma, sponsored by the All India Insti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: All India Institute of Medical Sciences | Conditions: Hepatocellular Carcinoma | Phase 2, Phase 3 | Status: UNKNOWN